Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-09 10:43 am Purchase | 2024-04-05 | 13G | PROTARA THERAPEUTICS INC TARA | CVI Investments, Inc. | 600,380 5.300% | 600,380 (New Position) | Filing History |
| 2024-04-04 10:15 am Purchase | 2024-03-28 | 13G | RENALYTIX PLC ADS RNLXY | CVI Investments, Inc. | 8,547,788 6.900% | 8,547,788 (New Position) | Filing History |
| 2024-02-16 11:28 am Purchase | 2024-02-08 | 13G | TENAX THERAPEUTICS INC PAR TENX | CVI Investments, Inc. | 204,027 9.900% | 204,027 (New Position) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | EVOFEM BIOSCIENCES INC PAR EVFM | CVI Investments, Inc. | 102,799 0.900% | 46,532 (+82.70%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | SIDUS SPACE INC SIDU | CVI Investments, Inc. | 0 0.000% | -26,010 (Position Closed) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | BITFARMS LTD COM BITF | CVI Investments, Inc. | 9,259,260 2.800% | -9,259,260 (-50.00%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | ENSERVCO CORPORATION ENSV | CVI Investments, Inc. | 1,411,740 4.900% | 411,740 (+41.17%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | ESPERION THERAPEUTICS INC ESPR | CVI Investments, Inc. | 0 0.000% | -5,500,000 (Position Closed) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | DUET ACQUISITION CORP DUET | CVI Investments, Inc. | 0 0.000% | -460,000 (Position Closed) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | ADITXT INC PAR $0.001 ADTX | CVI Investments, Inc. | 0 0.500% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | RYVYL INC PAR $0.001 RVYL | CVI Investments, Inc. | 17,032 9.900% | 1,554 (+10.04%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | XMAX INC PAR $ XMAX | CVI Investments, Inc. | 74,300 4.300% | -1 (-0.00%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | ICORECONNECT INC ICCT | CVI Investments, Inc. | 382,363 4.100% | -217,637 (-36.27%) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | GENETIC TECHNOLOGIES LTD SPONS GENE | CVI Investments, Inc. | 0 0.000% | -623,077,200 (Position Closed) | Filing History |
| 2024-02-14 2:14 pm Sale | 2023-12-31 | 13G | EBET INC EBET | CVI Investments, Inc. | 65,359 0.400% | -1 (-0.00%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | VERSUS SYS INC NO PAR VS | CVI Investments, Inc. | 100,000 3.800% | 47,917 (+92.00%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | GENPREX INC GNPX | CVI Investments, Inc. | 2,808 4.900% | 2,729 (+3454.43%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | EOS ENERGY ENTERPRISES INC EOSE | CVI Investments, Inc. | 9,800,990 4.900% | 1,800,990 (+22.51%) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | CVI Investments, Inc. | 4,321 9.900% | 2,159 (+99.86%) | Filing History |